Estudo pré-clínico do perfil farmacocinético, biodistribuição e atividade antifúngica de formulação lipossomal de voriconazol para uso intravenoso em infecções sistêmicas

Estudo pré-clínico do perfil farmacocinético, biodistribuição e atividade antifúngica de formulação lipossomal de voriconazol para uso intravenoso em infecções sistêmicas

Submitted by Liliane Ferreira (ljuvencia30@gmail.com) on 2018-09-06T11:19:09Z No. of bitstreams: 2 Tese - Danillo Fabrini Maciel Costa Veloso - 2018.pdf: 15996172 bytes, checksum: 30a5841de71ac68f55a18e1b917ed259 (MD5) license_rdf: 0 bytes, checksum: d41d8cd98f00b204e9800998ecf8427e (MD5) === Approv...

Full description

Bibliographic Details
Main Author:	Veloso, Danillo Fabrini Maciel Costa
Other Authors:	Lima, Eliana Martins
Format:	Others
Language:	Portuguese
Published:	Universidade Federal de Goiás 2018
Subjects:	Drug delivery Lipossomas Acumulação tecidual Infecções fúngicas sistêmicas Voriconazol Liposomal encapsulation Tissue accumulation Systemic fungal infections CIENCIAS DA SAUDE
Online Access:	http://repositorio.bc.ufg.br/tede/handle/tede/8862

Similar Items

Recurrent Acremonium infection in a kidney transplant patient treated with voriconazole: a case report Infecção recidivante por Acremonium em paciente transplantado renal tratado com voriconazol: relato de caso
by: Felipe Francisco Tuon, et al.
Published: (2010-08-01)

Pulmonary delivery of aqueous voriconazole solution
by: Tolman, Justin Andrew
Published: (2012)

Interaction between voriconazole and glimepiride
by: Shobha J, et al.
Published: (2010-01-01)

Treatment of invasive fungal infections: stability of voriconazole infusion solutions in PVC bags
by: Andréa I.H. Adams, et al.

Voriconazole-induced hypokalemia and hyponatremia and their correlations with voriconazole trough concentration
by: CHENG Lin, et al.
Published: (2020-07-01)

Eficacia anestesica da formulação lipossomal de articaina em ratos
by: Berto, Luciana Aranha, 1985-
Published: (2010)

Concomitant Treatment with Voriconazole and Flucloxacillin: A Combination to Avoid
by: Ruth Van Daele, et al.
Published: (2021-09-01)

Estudo da encapsulação do voriconazol em lipossomas: obtenção, caracterização e estudo de estabilidade
by: Benedetti, Naiara Ieza Gallo de Magalhães
Published: (2018)

Safety Profile of Voriconazole in Thai Patients: A Retrospective, Descriptive Study
by: Preecha Montakantikul, et al.
Published: (2015-06-01)

The effects of cytochrome P450 2C19 polymorphism on the metabolism of voriconazole in vitro
by: Xu RA, et al.
Published: (2018-11-01)

Drug–drug interaction study of imatinib and voriconazole in vitro and in vivo
by: Lin QM, et al.
Published: (2019-04-01)

Desenvolvimento e caracterização de lipossomas mucoadesivos para liberação ocular de fármacos
by: Sá, Fernando Augusto Pires de
Published: (2016)

Drug reservoir function of voriconazole impregnated human amniotic membrane: An in vitro study
by: Manali Hazarika, et al.
Published: (2021-01-01)

Voriconazole and posaconazole therapeutic drug monitoring: a retrospective study
by: Whitley M. Yi, et al.
Published: (2017-09-01)

A suspected case of autoinduction of voriconazole metabolism in a patient with cerebral aspergillosis
by: Ferguson MJ, et al.
Published: (2017-09-01)

Two Different Approaches for Oral Administration of Voriconazole Loaded Formulations: Electrospun Fibers versus β-Cyclodextrin Complexes
by: Panoraia I. Siafaka, et al.
Published: (2016-02-01)

Lidocaina lipossomal produzida em processo escalonavel : formulação, caracterização e testes biologicos
by: Almeida, Ana Claudia Pedreira de
Published: (2008)

Comparison of clinical pharmacology of voriconazole and posaconazole
by: Beata M. Sienkiewicz, et al.
Published: (2016-12-01)

A case of recurrent keratitis caused by Paecilomyces lilacinus and treated by voriconazole
by: Carolina Pelegrini Barbosa Gracitelli, et al.

Combined Impact of Inflammation and Pharmacogenomic Variants on Voriconazole Trough Concentrations: A Meta-Analysis of Individual Data
by: Léa Bolcato, et al.
Published: (2021-05-01)

Saliva for Precision Dosing of Antifungal Drugs: Saliva Population PK Model for Voriconazole Based on a Systematic Review.
by: Hannah Yejin Kim, et al.
Published: (2020-06-01)

Method for Therapeutic Drug Monitoring of Voriconazole and its Primary Metabolite Voriconazole-N-oxide in Human Serum using LC-MS/MS
by: Mendy ter Avest, et al.
Published: (2018-10-01)

Impact of CYP2C19 polymorphisms on serum concentration of voriconazole in iranian hematological patients
by: Sholeh Ebrahimpour, et al.
Published: (2017-01-01)

Generalized exfoliative skin rash as an early predictor of supratherapeutic voriconazole trough levels in a leukemic child: A case report
by: Ali Amanati, et al.
Published: (2020-09-01)

Uso de voriconazol en el período neonatal. Reporte de dos casos = Voriconazole use during the neonatal period. Report of two cases
by: Carvajal Kalil, Luis Fernando, et al.
Published: (2011-06-01)

Successful treatment of Chrysosporium keratitis with voriconazole
by: Thanathanee O, et al.
Published: (2017-03-01)

Monitoramento terapêutico de fluconazol com suporte farmacocinético em pacientes grandes queimados com internação prolongada para controle das infecções fúngicas
by: Michel Silveira Bragatto
Published: (2011)

Monitoramento terapêutico de fluconazol com suporte farmacocinético em pacientes grandes queimados com internação prolongada para controle das infecções fúngicas
by: Bragatto, Michel Silveira
Published: (2011)

A case of endogenous trichosporon endophthalmitis treated with micafungin and voriconazole
by: Harpreet Walia, et al.
Published: (2009-01-01)

Voriconazole Use in Children: Therapeutic Drug Monitoring and Control of Inflammation as Key Points for Optimal Treatment
by: José María Valle-T-Figueras, et al.
Published: (2021-06-01)

Relationship between voriconazole trough concentration and liver injury in elderly patients with lung invasive aspergillosis
by: CHENG Lin, et al.
Published: (2020-10-01)

Verapamil Inhibits Aspergillus Biofilm, but Antagonizes Voriconazole
by: Hasan Nazik, et al.
Published: (2017-09-01)

Voriconazole-induced periostitis
by: D.C. Fernández Ávila, et al.
Published: (2021-04-01)

Situation of anti-fungal resistance of species of the genus Candida in Peru
by: Susana Zurita Macalupú
Published: (2018-03-01)

Favorable Effects of Voriconazole Trough Concentrations Exceeding 1 μg/mL on Treatment Success and All-Cause Mortality: A Systematic Review and Meta-Analysis
by: Yuki Hanai, et al.
Published: (2021-04-01)

Voriconazole in Prevention and Treatment of Febrile Neutropenia
by: Hamidreza Taghva Masoumi, et al.
Published: (2018-02-01)

The utility of voriconazole therapeutic drug monitoring in a multi-racial cohort in Southeast Asia
by: Peijun Yvonne Zhou, et al.
Published: (2020-06-01)

An appraisal of antifungal impacts of nano-liposome containing voriconazole on voriconazole-resistant Aspergillus flavus isolates as a groundbreaking drug delivery system
by: Parviz Hassanpour, et al.
Published: (2020-03-01)

Intravenous delivery of a liposomal formulation of voriconazole improves drug pharmacokinetics, tissue distribution, and enhances antifungal activity
by: Danillo F. M. C. Veloso, et al.
Published: (2018-01-01)

The Impact of Plasma Protein Binding Characteristics and Unbound Concentration of Voriconazole on Its Adverse Drug Reactions
by: Zi-Qing-Yun Yuan, et al.
Published: (2020-04-01)